-
$500 million: Lilly introduces Nimbus' AMPK activator
Time of Update: 2022-10-20
Original link: AMPK activator has great potential in the treatment of metabolic diseases such as diabetes, NAFLD, and obesity, and with the clarity of mechanism research, translational research has also entered an accelerated stage, and has attracted more and more attention from multinational pharmaceutical companies.
-
Pharmaceutical injection grade polyethylene glycol PEG400cas25322-68-3
Time of Update: 2022-08-20
Pharmaceutical injection grade polyethylene glycol PEG400cas25322-68-3 polyethylene oxide resin is a high molecular weight homopolymer obtained by heterogeneous catalyzed ring-opening polymerization
-
The first quarterly report shows that the Chinese market has become a battleground for multinational pharmaceutical companies
Time of Update: 2022-05-08
Among them, most multinational pharmaceutical companies have achieved a year-on-year increase in performance .
The report shows that in the first quarter, Novartis Group’s net sales increased by 5% year-on-year to $12.
-
The AAV gene therapy company founded by the Chinese uses a lower dose to treat hemophilia A doctor Mai Meng broke the news
Time of Update: 2022-04-27
Here are some examples of candidate products that are progressing faster: ➤ BioMarin's valoctocogene roxaparvovec (valrox) In January 2022, the company announced Complete data for valrox in Phase 3 clinical study GENEr8-1, 134 subjects met all primary and secondary efficacy endpoints in the two-year analysis.
-
What is the performance of the blockbuster oncology drugs of multinational pharmaceutical giants
Time of Update: 2022-03-08
In 2021, O drugs for the first-line treatment of renal cell carcinoma, pleural mesothelioma, and gastric cancer will return to growth momentum, achieving sales revenue of US$7.
Tecentriq's 2021 financial report shows that Roche achieved total revenue of CHF 62.
-
Announcement of R&D expenses of 71 pharmaceutical companies: Yiling, Baiyunshan, China Resources Sanjiu
Time of Update: 2022-01-26
Image source: WeChat public account "Pharmaceutical Aspects"Relevant people in the industry believe that according to the current development trend of new traditional Chinese medicines, the market size is expected to exceed one trillion yuan in 2022, and will reach 1.
-
900 million oral hypoglycemic drug Jiangsu pharmaceutical company's first review
Time of Update: 2022-01-12
A few days ago, the official website of the State Food and Drug Administration showed that the voglibose tablets of Suzhou Sinochem Pharmaceutical Industry passed the consistency evaluation, which is the first in China .
-
Two more senior executives of multinational pharmaceutical companies may switch to local companies
Time of Update: 2021-12-29
Eid, an expert in the medical field, officially announced that he had joined Hengrui Pharmaceuticals as executive vice president, chief medical officer and head of global drug development.
-
Domestic anti-tumor drugs ushered in a big outbreak, local pharmaceutical companies are vying to exert their strength
Time of Update: 2021-12-26
It is understood that, in addition to Shandong New Times Pharmaceuticals recently submitted and accepted application for the 4 types of generic marketing of azacitidine for injection, many innovative anti-tumor drugs have also been approved for clinical use.
-
As China vigorously promotes the development of pharmaceutical innovation, multinational pharmaceutical companies are accelerating reforms
Time of Update: 2021-11-15
Based on the above, the industry believes that behind the drastic reforms of multinational pharmaceutical companies, in addition to being affected by the implementation of China's pharmaceutical industry policies in recent years, more importantly, the trend of the Chinese market environment is gradually shifting from generic drugs to innovation .
-
The best pharmaceutical companies in the hearts of American employees: Horizon, Genentech, and AbbVie are among the top three
Time of Update: 2021-07-15
The top ranking is for the Horizon culture and how we care for our employees and respond to patients.
" Reference source: Horizon, Roche's Genentech, AbbVie and Neurocrine rank as top pharma places to work in annual poll
-
Eastern Sunshine Herbal Escitalopram Oxalate Tablets Entered the Administrative Approval Stage
Time of Update: 2021-03-29
Recently, Dongyang Sun Pharmaceutical has entered the administrative approval stage with the imitation of escitalopram oxalate tablets reported for production in category 4, and is expected to become the company's second antidepressant approved for marketing.
-
Shumeile generic drugs into the clinical phase III AbbVie pressure mountain
Time of Update: 2021-02-13
However, if the best-selling drug is about to lose patent protection, then the smell of generic drug research and development will make the company's money tree instantly disappear.
recently, researchers from Baxalta and Momta Biopharmaceuticals announced that M923, a generic drug product developed jointly by the two companies, was entering clinical phase III.
-
Beijing-Tianjin-Hebei intends to push the negative list of market access Industrial enterprises to take the brunt
Time of Update: 2021-01-27
China Coatings Network News: In order to undo the functions of the non-capital, accelerate the integration of Beijing, Tianjin and Fujian to promote the speed of the three provinces and cities will be separately formulated industrial access directory, the implementation of negative market access list management.
-
Sichuan pharmaceutical company hits the first company with 2 billion large varieties
Time of Update: 2021-01-09
Figure 3:2020H1 osteosterol enterprise competition pattern source: Mi net China's public medical institutions terminal competition pattern market domestic osteotisanol only Zhengda Pharmaceutical (Qingdao) was approved, the product is softgels, the enterprise also submitted a consistent evaluation of supplementary applications in July this year, is currently in review and approval.
